Your browser doesn't support javascript.
The efficacy and safety of IBI314 on delta and omicron variant of SARS-CoV-2: First-in-human evidence.
Sang, Ling; Cheng, Bo; Yu, Yuheng; Xi, Yin; Wang, Yun; Fan, Bingdong; Li, Jijie; Dai, Jingtao; Gan, Guifen; Tong, Shijun; Sun, Bin; Qi, Xiaojing; Liang, Wenhua; He, Jianxing; Zhong, Nanshan.
  • Sang L; Department of Intensive Care Unit, Guangzhou Institute of Respiratory Health, State Key Laboratory of Respiratory Disease and National Clinical Research Center for Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510120, China; Guangzhou Laboratory, Guang
  • Cheng B; Department of Thoracic Surgery and Oncology, State Key Laboratory of Respiratory Disease and National Clinical Research Center for Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou Institute of Respiratory Health, Guangzhou 510120, China; Guangzhou Laborat
  • Yu Y; Department of Intensive Care Unit, Guangzhou Institute of Respiratory Health, State Key Laboratory of Respiratory Disease and National Clinical Research Center for Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510120, China; Guangzhou Laboratory, Guang
  • Xi Y; Department of Intensive Care Unit, Guangzhou Institute of Respiratory Health, State Key Laboratory of Respiratory Disease and National Clinical Research Center for Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510120, China; Guangzhou Laboratory, Guang
  • Wang Y; Department of Emergency Intensive Care Unit (EICU), Qinghai Provincial Fourth People's Hospital, China.
  • Fan B; Department of Emergency Intensive Care Unit (EICU), Qinghai Provincial Fourth People's Hospital, China.
  • Li J; Department of Respiratory Medicine, Qinghai Provincial Fourth People's Hospital, China.
  • Dai J; Department of Respiratory Intensive Care Medicine, The Qinghai Provincial Fourth People's Hospital, China.
  • Gan G; Department of Critical Care Medicine, The Affiliated Hospital of Qinghai University, China.
  • Tong S; Department of Critical Care Medicine, The Affiliated Hospital of Qinghai University, China.
  • Sun B; Department of Critical Care Medicine, Qinghai Provincial People's Hospital, China.
  • Qi X; Department of Respiratory and Critical Care Medicine, Qinghai Provincial People's Hospital, China.
  • Liang W; Department of Thoracic Surgery and Oncology, State Key Laboratory of Respiratory Disease and National Clinical Research Center for Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou Institute of Respiratory Health, Guangzhou 510120, China; Guangzhou Laborat
  • He J; Department of Thoracic Surgery and Oncology, State Key Laboratory of Respiratory Disease and National Clinical Research Center for Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou Institute of Respiratory Health, Guangzhou 510120, China; Guangzhou Laborat
  • Zhong N; Guangzhou Laboratory, Guangzhou International Biotech Island, Guangzhou 510320, China; Department of Respiratory Medicine, State Key Laboratory of Respiratory Disease & National Clinical Research Center for Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guang
J Infect ; 85(3): 334-363, 2022 09.
Article in English | MEDLINE | ID: covidwho-1882223
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Topics: Variants Limits: Humans Language: English Journal: J Infect Year: 2022 Document Type: Article

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Topics: Variants Limits: Humans Language: English Journal: J Infect Year: 2022 Document Type: Article